Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2020CirculationOpen Access

Medical treatment or catheter ablation are considered first-line therapies in most patients with PVCs associated with symptoms or a reduced left ventricular ejection fraction.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

GMGregory M. Marcus

Discussion

Loading...

Member takes

Overview

Informs PVC management decisions; leaves open need for RCTs to refine strategies and outcomes.

Structured PICO

P
Population
Individuals with premature ventricular complexes (PVCs)
I
Intervention
Medical treatment (β-blockers, nondihydropyridine calcium channel blockers, other antiarrhythmic drugs) or catheter ablation

This review summarizes the evaluation, prognosis, and management of premature ventricular complexes, emphasizing medical therapy or catheter ablation for symptomatic patients or those with reduced ejection fraction.

Limitations

  • Ongoing uncertainty regarding the most informative predictors of adverse outcomes
  • Need for original research to identify individuals at risk for PVC-induced cardiomyopathy

Cite This Study

Gregory M. Marcus (2020) studied this question.

synapsesocial.com/papers/69d5708e75589c71d767dd17https://doi.org/10.1161/circulationaha.119.042434
View Full Paper
Ask AI
Bookmark
Share